Le Lézard
Classified in: Health, Business
Subjects: ERN, CCA

PharmaCielo to Hold Conference Call to Review Third Quarter 2019 Financial Results


TORONTO, Nov. 25, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTC: PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announces today that it will host a conference call on Monday, November 25th, 2019, at 5:00 p.m. ET to discuss its third quarter financial results and provide investors with key business highlights. The call will be chaired by David Attard, CEO; David Gordon, CCO and Scott Laitinen, CFO.

PharmaCielo (CNW Group/PharmaCielo Ltd.)

CONFERENCE CALL DETAILS

Date: November 25th, 2019 | Time: 5:00pm ET

Participant Dial-in: 416-764-8688 or 1-888-390-0546

Replay Dial-in: 416-764-8677 or 1-888-390-0541

(Available for 2 weeks)

Conference ID: 30043730

Playback #: 043730

Listen to webcast: event.on24.com 

About PharmaCielo

PharmaCielo Ltd. (TSXV:PCLO, OTC:PHCEF) is a global company, headquartered in Canada, with a focus on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its nursery and propagation centre located in Rionegro, Colombia.

The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia's ideal location will play in building a sustainable business in the medical cannabis industry, and the Company, together with its directors and executives, is executing on a business plan focused on supplying the international marketplace.

For further information:
www.PharmaCielo.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE PharmaCielo Ltd.


These press releases may also interest you

at 08:00
Activity in the behavioral health care M&A market slowed in the fourth quarter of 2019, down 21% with 15 publicly announced transactions, compared with 19 transactions in the third quarter, according to data from HealthCareMandA.com. The decline in...

at 05:00
111, Inc. ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the sixth episode in its 111 Insight series. The title announced today, The Impact of Chinese Policies to Medical Industry, is...

at 01:08
Critically acclaimed singer, songwriter and longtime St. Jude supporter Brad Paisley made a surprise appearance on Saturday night in front of more than 800 country music industry attendees ? including radio personalities, artists, executives, label...

at 00:00
Governor Phil Murphy signed two bills this past week that improve the safety of New Jersey student-athletes. "By enacting these measures today, we are making sure that student-athletes have the resources and protections to enjoy school sports...

18 jan 2020
This Thursday, the coalition and Mayor Breed will cut the ribbon for Trans Home SF on Washington Street, San Francisco's first home for trans adults. Trans Home SF on Washington Street is a transitional housing program that will provide much needed...

18 jan 2020
Therap's electronic documentation software for the Intellectual and Developmental Disabilities (I/DD) and Long-Term Supports & Services (LTSS) community allows case managers to access information on individuals in their caseload, even across multiple...



News published on 25 november 2019 at 14:28 and distributed by: